OcugenNeoCart® (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicinesMALVERN, Pa., May 24, 2022...
OcugenNeoCart® (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicinesMALVERN, Pa., May 24, 2022...